Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1200 participants
OBSERVATIONAL
2008-11-30
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
NCT00374712
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
NCT00772382
Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients
NCT05586867
Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD
NCT02112136
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function
NCT02840812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hemodialysis patients
Adult patients undergoing maintenance dialysis since at leat three months
blood sample
Searching for Klotho variants in DNA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample
Searching for Klotho variants in DNA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospices Civils de Lyon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FOUQUE Denis, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
LEGRAND Eric, MD
Role: PRINCIPAL_INVESTIGATOR
CH Annonay
KAARASLAN Huseyin, MD
Role: PRINCIPAL_INVESTIGATOR
CH Bourgoin Jallieu
ABOKASEM Ayman, MD
Role: PRINCIPAL_INVESTIGATOR
CH Chalon/saône
LATAILLADE Claire Dominique, MD
Role: PRINCIPAL_INVESTIGATOR
CH Sallanches
KUENTZ François, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Dialyse eaux claires
HACHACHE Toufic, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Grenoble - La Tronche
LEITIENNE Philippe, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
ARKOUCHE Walid, MD
Role: PRINCIPAL_INVESTIGATOR
AURAL - Lyon
HEYANI Ahmed, MD
Role: PRINCIPAL_INVESTIGATOR
CH MACON
HANNOUN Jacques, MD
Role: PRINCIPAL_INVESTIGATOR
CH Villefranche/saône
COMBARNOUS François, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique du Tonkin VILLEURBANNE
MAUREAUGANDRY Xavier, MD
Role: PRINCIPAL_INVESTIGATOR
AGDUC - Montélimar
SIRAJEDINE Mohamed, MD
Role: PRINCIPAL_INVESTIGATOR
CH ROMANS/ISERE
JEAN Ahmed, MD
Role: PRINCIPAL_INVESTIGATOR
Centre du Rein - Tassin la demi lune
DENICOLA Cora, MD
Role: PRINCIPAL_INVESTIGATOR
Calydial - CH Viennes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Edouard Herriot
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Marcais C, Maucort-Boulch D, Drai J, Dantony E, Carlier MC, Blond E, Genet L, Kuentz F, Lataillade D, Legrand E, Moreau-Gaudry X, Jean G, Fouque D; ARNOGENE Project. Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3154-3161. doi: 10.1210/jc.2017-00104.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007.471/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.